Iohexol
Radiographic Contrast Agent — VARIOUS
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Iohexol is an ofp drug in the Radiographic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1985. Its mechanism of action is classified as X-Ray Contrast Activity.
- Approval status: ofp (first approved 1985 by the FDA).
- Drug class: Radiographic Contrast Agent.
- Mechanism of action: X-Ray Contrast Activity.
- ATC code: V08AB02 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
- Molecular formula: C19H26I3N3O9; molecular weight 821.14 g/mol.
Mechanism & targets
| Mechanism of action (MoA) | X-Ray Contrast Activity |
|---|---|
| Established pharmacologic class | Radiographic Contrast Agent |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1985-12-26 | FDA | — | GE HEALTHCARE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08AB02 | VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Sneezing | 2032.2 |
| Urticaria | 1726.3 |
| Contrast media reaction | 1254.3 |
| Contrast media allergy | 1044.2 |
| Pruritus | 1007.1 |
| Erythema | 863.8 |
| Extravasation | 515.8 |
| Throat irritation | 504.4 |
| Throat tightness | 490.9 |
| Anaphylactic reaction | 416.5 |
| Chills | 399.5 |
| Dyspnoea | 368.9 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Iohexol is on its molecule page.
| Molecular formula | C19H26I3N3O9 |
|---|---|
| Molecular weight | 821.14 g/mol |
| CAS number | — |
| InChIKey | NTHXOOBQLCIOLC-UHFFFAOYSA-N |
| PubChem CID | 3730 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Iohexol work?
Iohexol is classified as X-Ray Contrast Activity.
When was Iohexol first approved?
Iohexol was first approved by the FDA in 1985.
What drug class does Iohexol belong to?
Iohexol is in the Radiographic Contrast Agent class.
What is the chemical formula of Iohexol?
Iohexol has the molecular formula C19H26I3N3O9 and a molecular weight of 821.14 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1461 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200455 — compound record and bioactivity
- PubChem CID 3730 — chemical identifiers
- DrugBank DB01362 — drug record
- FDA UNII 4419T9MX03 — substance identity
- DailyMed: FDA labels for Iohexol — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.